Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bryostatin 1 in Relapsed Multiple Myeloma
NCT00002907Phase 2Completed
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Start
- Jan 1997
- Primary completion
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bryostatin-1 in multiple myeloma (MM), sponsored by Barbara Ann Karmanos Cancer Institute. Started Jan 1997; status: completed.
02
Drugs
bryostatin-1
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00002907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002907.